Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer.

Shaorong ZhaoTeng PanJinhai DengLixia CaoJose M VicencioJingjing LiuGuanglin ZhouTony T Ng Jin Zhang

Published in: British journal of cancer (2022)

Our data suggests exo-miR-181b-5p as a prognostic biomarker and a therapeutic potential for exo-miR-181b-5p inhibitors in the treatment of doxorubicin-resistant BC patients.

Keyphrases

end stage renal disease
drug delivery
ejection fraction
newly diagnosed
chronic kidney disease
dna damage
prognostic factors
signaling pathway
electronic health record
machine learning